Litio para el síndrome de Leigh: ¿daño, beneficio o ambos?

dc.contributor.author	Finsterer, Josef
dc.contributor.author	Maeztu, Concepción
dc.date.accessioned	2026-05-13T10:41:45Z
dc.date.available	2026-05-13T10:41:45Z
dc.date.issued	2021-07
dc.identifier.citation	Finsterer J, Maeztu C, Basterreche N. Litio para el síndrome de Leigh: ¿daño, beneficio o ambos? Actas Esp Psiquiatr. julio de 2021;49(4):196-8. PubMed PMID: 34195974.
dc.identifier.issn	1139-9287
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/26533
dc.description.abstract	With interest we read the article by Basterreche et al. about a 23yo female with Leigh syndrome diagnosed at age 4y and manifesting with severe psychomotor impairment, severe self-harm, hetero-aggressions, bilateral hypodensities of the basal ganglia, and cerebellar atrophy.
dc.language.iso	spa
dc.publisher	JUAN JOSE LOPEZ-IBOR FOUNDATION
dc.rights	Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/deed.es	*
dc.subject.mesh	Child, Preschool
dc.subject.mesh	Female
dc.subject.mesh	Humans
dc.subject.mesh	Leigh Disease/drug therapy
dc.subject.mesh	Lithium
dc.title	Litio para el síndrome de Leigh: ¿daño, beneficio o ambos?
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	34195974
dc.relation.publisherversion	https://actaspsiquiatria.es/index.php/actas/article/download/302/443/455
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.journal.title	Actas Españolas de Psiquiatría
dc.identifier.essn	1578-2735